PHA Scientific Leadership Council

PHA’s Scientific Leadership Council (SLC) is composed of 28 leaders in the field of pulmonary hypertension. Coordinating the medical arm of PHA, they provide medical and scientific leadership and guidance for the mission of the Pulmonary Hypertension Association and lead the development of the wide array of all PHA’s medical programming.

SLC members proactively facilitate the development of new knowledge about pulmonary hypertension, develop educational resources for medical and public audiences, and advocate to raise awareness about pulmonary hypertension. The SLC was formed out of the PHA philosophy that patients and medical professionals can achieve more working together.

Members of the SLC are clinicians, research scientists and nurses in medical centers recognized for performing outstanding research and providing excellent care for patients with pulmonary hypertension.

Members of the Scientific Leadership Council (SLC) serve as PHA’s leadership and are cardiologists, pulmonologists and rheumatologists – leading PH experts who branch out into all areas of scientific exploration and treatment of pulmonary hypertension. Not only do they guide the vast array of medical education PHA offers to both the medical and patient communities, they also are involved in the development of cutting-edge research exploring various aspects of PH such as the implications of genetics in pulmonary hypertension, treatments for children living with PH, PH and associated diseases, and much more.

Many past and present members of the SLC lead in the development of the journal Advances in Pulmonary Hypertension and the comprehensive treatment fact sheets and consensus statements available as resources on our website.

PHA Scientific Leadership Council Members

Ronald J. Oudiz, MDSLC, Chair
Ronald J. Oudiz, M.D.
Professor of Medicine
Director, Liu Center for Pulmonary Hypertension
LA Biomedical Research Institute at Harbor – UCLA Medical Center
Torrance, Calif.
Term Ends June 2022

Murali M. Chakinala, MDSLC, Chair Elect
Murali M. Chakinala, M.D., FCCP

Professor of Medicine
Washington University School of Medicine
Division of Pulmonary and Critical Care
St. Louis, Mo.
Term Ends June 2024

Erika S. Berman Rosenzweig, MDSLC, Immediate Past Chair
Erika S. Berman Rosenzweig, M.D.

Professor of Pediatrics (in Medicine)
Columbia University Medical Center – New York Presbyterian Hospital
New York, N.Y.
Term Ends June 2020

Committees

Todd M. Bull, M.D.
Chair, SLC Research Committee
Professor of Medicine
Director, Pulmonary Vascular Disease Center
Director, Comprehensive Lung and Breathing Program
Associate Head of Clinical Affairs
Pulmonary Sciences and Critical Care Medicine and Cardiology
University of Colorado
Denver, Colo.

Members of the Research Committees are leading researchers in the field of pulmonary hypertension. They guide the growth and development of PHA’s research program with over $15 million in committed funds for pulmonary hypertension research.

Mission Statement and Charge

The Research Committee of the Scientific Leadership Counsel was created to support PHA in its mission to advance PH research in the field for both patient and professional populations. In order to grow the research opportunities, information and resources available to these communities, the Research Committee is charged with supporting the following activities:

  1. The Research Committee will facilitate knowledge of research, including basic and clinical studies, and its findings to patient and professional communities through PHA’s communication channels, including Pathlight, Advances in Pulmonary Hypertension, the PHA Online University and PHA Classroom.
  2. The Research Committee will actively reach out to relevant agencies to initiate and strengthen relationships so that there will be opportunities for collaboration to enhance research funds and resources sharing.
  3. The Research Committee will advance the goals of the PHA to become a funding body for new research initiatives.
  4. The Research Committee will encourage the development of new PH research and researchers through mentorship by established research leaders in the field who will recruit and lead newer researchers.

The Research Committee will commence periodically to discuss progress, evaluate goals and plan.

Todd Bull, M.D. (chair)
Associate Professor of Medicine
University of Colorado
Aurora, Colo.

Eric D. Austin, M.D., MSCI
Director, Vanderbilt Pediatric Pulmonary Hypertension Program
Associate Professor of Pediatrics
Vanderbilt University
Nashville, Tenn.

Karen A. Fagan, M.D.
Associate Professor of Medicine
Chief of Pulmonology, Critical Care
University of South Alabama
Mobile, Ala.

Matthew R. Lammi, M.D.
Associate Professor of Medicine
Louisiana State University
New Orleans

Vinicio A. de Jesus Perez, M.D.
Assistant Professor of Medicine
Stanford University
Stanford, Calif.

Mardi Gomberg-Maitland, M.D., M.Sc.
Chair, SLC Education Committee
Director of the Pulmonary Hypertension Program
Medical Faculty Associates, George Washington University, Heart and Vascular Institute
Washington, D.C.

The Education Committee provides guidance in the development of patient educational material such as the Patients Survival Guide, develops current information on the latest treatments and devises consensus statements on different aspects of living with pulmonary hypertension.

Mission Statement and Charge

The Education Committee of the Scientific Leadership Council was created to support PHA in its mission to advance PH education in the field for both patient and professional populations. In order to grow the educational opportunities, information and resources available to these communities, the Education Committee is charged with the following activities:

  1. The Education Committee will facilitate education through the development of practice consensus statements and treatment fact sheets.
  2. The Education Committee will actively work with the PHPN to develop educational materials.
  3. The Education Committee will support the goals of the PHA Medical Education Fund, including projects for the Online University and in-person CME education events.

The Education Committee will convene periodically to discuss progress, evaluate goals and plan.

Mardi Gomberg-MaitlandM.D., M.Sc. (chair)
Professor of Medicine, VCU School of Medicine
Director of RV Failure, HFpEF and Cardio-Oncology Programs
Co-Director of the Pulmonary Vascular Disease Program
Inova Heart and Vascular Institute
Falls Church, Va.

Sonja BartolomeM.D.
Director of Liver Transplant Critical Care
Associate Professor, Internal Medicine
UT Southwestern Medical Center
Dallas, Texas

Michael J. Cuttica, M.D., M.S.
Associate Professor of Medicine
Northwestern University
Chicago

Jeffrey Fineman, M.D.
Pediatric Critical Care Specialist
Critical Care Division Chief
University of California, San Francisco
Benioff Children’s Hospital
San Francisco

David C. Ishizawar, M.D.
Associate Professor
Froedtert & the Medical College of Wisconsin
Milwaukee

Adolfo Kaplan, M.D.
Associate Director
Pulmonary & Sleep Center of The Valley
McAllen, Texas

Jamie L. W. Kennedy, M.D., FACC
Assistant Professor
Advanced Heart Failure and Transplant Cardiology
Medical Director, Coronary Care Unit and Pulmonary Hypertension Center
University of Virginia
Charlottesville, Va.

John J. Ryan, M.D.
Director, Pulmonary Hypertension Center
University of Utah
Salt Lake City, Utah

Namita SoodM.D.
Associate Professor, Pulmonary, Allergy, Critical Care & Sleep
Ohio State University, Wexner Medical Center
Columbus, Ohio

Corey E. Ventetuolo, M.D., M.S.
Assistant Professor of Medicine and Health Services, Policy, and Practice, The Warren Alpert Medical School of Brown University
Associate Director, Pulmonary Hypertension Center
Medical Director, Adult Extracorporeal Life Support Program
Director of Clinical Research, Pulmonary Division
Rhode Island Hospital
Providence, R.I.

Kimberly Jackson, R.N., chair, PHPN Education Committee
Nurse Cardiovascular Coordinator
University of Kentucky, Gill Heart Institute
Lexington, Ky.

Members

Steven H. Abman, M.D.
Professor, Department of Pediatrics
Director, Pediatric Heart Lung Center
University of Colorado School of Medicine
Children’s Hospital Colorado
Aurora, Colo.
Term Ends June 2020

William R. Auger, M.D.
Professor of Clinical Medicine
Administrative Director, Pulmonary PTE Program
UCSD Medical Center
La Jolla, Calif.
Term Ends June 2020

Sonja Bartolome, M.D.
Associate Professor, Internal Medicine
Director, Liver Transplant Critical Care
University of Texas Southwestern Medical Center
Dallas, Texas
Term Ends June 2021

Todd M. Bull, M.D.
Professor of Medicine
Director, Pulmonary Vascular Disease Center
Director, Comprehensive Lung and Breathing Program
Associate Head of Clinical Affairs
Pulmonary Sciences and Critical Care Medicine and Cardiology
University of Colorado
Denver, Colo.
Term Ends June 2020

Kelly Chin, M.D.
Associate Professor, Internal Medicine
Director, Pulmonary Hypertension Program
UT Southwestern Medical Center
Dallas, Texas
Term Ends June 2020

Lorinda Chung, M.D.
Assistant Professor of Medicine
Stanford University
Palo Alto, Calif.
Term Ends June 2020

Vinicio A. de Jesus Perez, M.D., FCCP, FAHA, ATSF
Associate Professor of Medicine (UTL)
Stanford Adult Pulmonary Hypertension Clinic
Co-Director, Stanford Translational Investigator Program
Stanford, Calif.
Terms Ends June 2021

Teresa De Marco, M.D.
Director of Advanced Heart Failure and Pulmonary Hypertension
Medical Director of Heart Transplantation
University of California, San Francisco
San Francisco, Calif.
Term Ends June 2022

Ankit A. Desai, M.D., FACC, FAHA
Associate Professor of Medicine
Krannert Institute of Cardiology
Indiana University
Indianapolis, Ind.
Term Ends June 2020

Jeffrey Fineman, M.D.
Pediatric Critical Care Specialist
Critical Care Division Chief
University of California, San Francisco
Benioff Children’s Hospital
San Francisco. Calif.
Term Ends June 2021

Robert P. Frantz, M.D.
Director, Pulmonary Hypertension Clinic
Professor of Medicine
Mayo Clinic
Rochester, Minn.
Term Ends June 2021

Mardi Gomberg-Maitland, M.D., M.Sc.
Director of the Pulmonary Hypertension Program
Medical Faculty Associates, George Washington University, Heart and Vascular Institute
Washington, D.C.
Term Ends June 2022

Anna Hemnes, M.D.
Associate Professor of Medicine
Assistant Director, Pulmonary Vascular Center
Vanderbilt University
Nashville, Tenn.
Term Ends June 2022

Steven Kawut, M.D., M.S.
Professor of Medicine and Epidemiology
Director, Pulmonary Vascular Disease Program
Perelman School of Medicine at the University of Pennsylvania
Philadelphia
Term Ends June 2022

Tim Lahm, M.D.
Associate Professor of Medicine and Cellular & Integrative Physiology
Division of Pulmonary, Critical Care, Sleep and Occupational Medicine
Indiana University School of Medicine
Indianapolis, Ind.
Term Ends June 2020

Deborah J. Levine, M.D.
Director of Pulmonary Hypertension Clinic
Medical Director of Inpatient and Outpatient Lung Transplantation
San Antonio, Texas
Term Ends June 2021

Roberto F. Machado, M.D.
Dr. Calvin H. English Professor of Medicine
Chief, Division of Pulmonary, Critical Care, Sleep, and Occupational Medicine
Indiana University Department of Medicine
Indianapolis, Ind.
Term Ends June 2020

Lana Melendres-Groves, M.D.
Medical Director, Pulmonary Hypertension Program
Associate Professor, Dept. of Internal Medicine
Pulmonary & Critical Care Division
University of New Mexico
Albuquerque, N.M.
Term Ends June 2022

John J. Ryan, M.D., FACC, FAHA
Director, Pulmonary Hypertension Center
University of Utah
Salt Lake City, Utah
Term Ends June 2021

Jeffrey S. Sager, M.D., MSCE
Director, Cottage Pulmonary Hypertension Center
Santa Barbara Pulmonary Consultants
Santa Barbara, Calif.
Term Ends June 2022

Oksana A. Shlobin, M.D., FCCP
Director, Pulmonary Hypertension Program
Director of Education, Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital
Associate Professor
Georgetown University School of Medicine
Virginia Commonwealth University School of Medicine
Term Ends June 2020

Thenappan Thenappan, M.D.
Associate Professor of Medicine, Cardiovascular Division
University of Minnesota
Minneapolis, Minn.
Term Ends June 2021

Corey E. Ventetuolo, M.D., M.S.
Assistant Professor of Medicine and Health Services, Policy, and Practice, The Warren Alpert Medical School of Brown University
Associate Director, Pulmonary Hypertension Center
Medical Director, Adult Extracorporeal Life Support Program
Director of Clinical Research, Pulmonary Division
Rhode Island Hospital
Providence, R.I.
Terms Ends June 2021

Timothy L. Williamson, M.D.
Associate Professor of Medicine
Director, Center for Pulmonary Arterial Hypertension
University of Kansas Medical Center
Kansas City, Kan.
Term Ends June 2020

Delphine Yung, M.D.
Associate Professor
Center for Clinical and Translational Research
Seattle Children’s Hospital
Seattle, Wash.
Term Ends June 2022

Liaisons

Fran Rogers, M.S.N., CRNP
PH Professional Network Liaison
Chair, PH Professional Network
Temple University Hospital
Philadelphia
Term Ends June 2020

Cheri Abbott, R.N., CCRP
PH Professional Network Liaison
Chair-Elect, PH Professional Network
University of Colorado School of Medicine
Denver, Colo.
Terms Ends June 2022

Nicole Reid, R.N., B.S.N.
National Capital Poison Center
Washington, D.C.
Patient Liaison
Term Ends June 2021

SLC Distinguished Advisory Committee

David B. Badesch, M.D.
Professor of Medicine
Clinical Director, Pulmonary Hypertension Center
University of Colorado Health Sciences Center
Aurora, Colo.

Bruce Brundage, M.D.
Professor of Medicine Emeritus
David Geffen School of Medicine at UCLA
Bend, Ore.

Richard N. Channick, M.D.
Associate Professor of Medicine
Harvard Medical School
Director, Pulmonary Hypertension Program
Massachusetts General Hospital
Boston, Mass.

C. Gregory Elliott, M.D.
Professor of Medicine
University of Utah School of Medicine
Murray, Utah

Karen A. Fagan, M.D.
Chief of Pulmonology, Critical Care
Professor of Internal Medicine and Pharmacology
University of South Alabama
Mobile, Ala.

Michael D. McGoon, M.D.
Professor Emeritus of Medicine
Mayo Clinic
Rochester, Minn.

Vallerie V. McLaughlin, M.D.
Director, Pulmonary Hypertension Program
Kim A. Eagle, MD, Endowed Professor in Cardiovascular Medicine
University of Michigan CVC Cardiovascular Medicine
Ann Arbor, Mich.

John H. Newman, M.D.
Elsa S. Hanigan Professor of Pulmonary Medicine
Director, Pulmonary & Critical Care Fellowship Program
Vanderbilt University School of Medicine
Nashville, Tenn.